Trial intelligence / Profile preview

Cannabinoids for oral mucositis during head and neck cancer treatment

RBR-8g2q8q5Phase 3Recruiting

Sponsor
Universidade Federal de Goiás
Start
Feb 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of cannabidiol in stomatitis (3 arms), sponsored by Universidade Federal de Goiás. Started Feb 2023; status: recruiting.

02

Drugs

cannabidiol
03

Conditions

stomatitis

Beyond the preview

Go deeper on RBR-8g2q8q5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-8g2q8q5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call